| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net income (loss) before provision for income taxes | 2,643 | -5,459 | -13,648 | -13,888 |
| (benefit from) provision for income taxes | -262 | 402 | 1,029 | 347 |
| Net income (loss) | 2,905 | -5,861 | -14,677 | -14,235 |
| Net income (loss) per share, basic (in dollars per share) | 0.06 | -0.12 | -0.3 | -0.3 |
| Net income (loss) per share, diluted (in dollars per share) | 0.05 | -0.12 | -0.3 | -0.3 |
| Weighted-average shares of common stock outstanding, basic (in shares) | 50,639,231 | 49,726,823 | 48,889,058 | 47,782,619 |
| Weighted-average shares of common stock outstanding, diluted (in shares) | 56,993,841 | 49,726,823 | 48,889,058 | 47,782,619 |
Mirum Pharmaceuticals, Inc. (MIRM)
Mirum Pharmaceuticals, Inc. (MIRM)